Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.35%)
At close: Sep 10, 2026 · 4:00 PM EDT

Celularity (CELU) Preferred Shares (2025)

Celularity's (CELU) quarterly Preferred Shares came in at $2.2 million in Q4 2025.

Analysis

Celularity (CELU) Preferred Shares (2025) Analysis & Trends

Celularity (CELU) has reported Preferred Shares for 1 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Preferred Shares changed N/A year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.2 million, changed N/A from the prior year.
  • Preferred Shares was $2.2 million for Q4 2025 at Celularity.
  • Over five years, Preferred Shares peaked at $2.2 million in Q4 2025 and troughed at $2.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - -
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 2,000.00
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -
6 Beam Therapeutics 2.55 Bn 2.55 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Celularity 36.35 Mn 30.17 Mn -3.27 Mn 2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.22 Mn